肿瘤外科与整形外科医生在即刻乳房再造信息提供及个人观点上的差异
该研究通过在线调查(35题)比较了118名肿瘤外科医生与71名整形外科医生对即刻乳房再造(IBR)的术前信息提供及禁忌症个人观点。所有医生均与患者讨论IBR可能性,但整形外科医生更常讨论并发症(100% vs 79%,P<0.001)和美学效果(99% vs 83%,P=0.001)。两组对IBR禁忌症的判断存在差异:整形外科更常报告患者相关伤口愈合风险因素,肿瘤外科更常报告肿瘤学禁忌症。
要点
- 所有医生均讨论IBR可能性,但整形外科更常提供并发症和美学效果信息。
- 整形外科更常将年龄>75岁、乳房>D罩杯、BMI>40 kg/m²、吸烟(假体)、心肺合并症(自体重建)和放疗视为禁忌。
- 肿瘤外科更常将肿瘤分期≥cT3、淋巴结分期≥cN2和化疗视为IBR禁忌。
核心结论
- 所有受访医生均与患者讨论IBR可能性,但整形外科医生更常提供个体化信息。
- 医生对IBR禁忌症的观点存在差异:整形外科更关注伤口愈合相关患者因素,肿瘤外科更关注肿瘤学禁忌症。
- 医生间就IBR禁忌症达成共识可能优化患者咨询和共享决策。
研究设计与样本
- 在线调查(35个问题),包括受访者人口学信息、IBR信息提供及按技术分类的潜在禁忌症问题。
主要发现
- 并发症讨论频率:肿瘤外科79% vs 整形外科100%(P < 0.001)。
- 美学效果讨论频率:肿瘤外科83% vs 整形外科99%(P = 0.001)。
- 整形外科更常将年龄>75岁、乳房大小>D罩杯、BMI>40 kg/m²、吸烟(假体再造)、肺/心脏合并症(自体重建)和放疗视为禁忌症。
- 肿瘤外科更常将肿瘤分期(≥cT3)、淋巴结分期(≥cN2)和化疗视为IBR禁忌症。
临床怎么用
- 整形与烧伤科智能体医生应意识到肿瘤外科与整形外科在IBR信息提供和禁忌症判断上的差异,促进多学科沟通。
- 在患者咨询中,应确保全面讨论并发症和美学效果,并综合考虑患者相关风险因素和肿瘤学因素。
- 推动医生间关于IBR禁忌症的共识,以优化共享决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immediate breast reconstruction (IBR) may improve quality of life of patients receiving mastectomy. However, a significant hospital variation exists in the use of IBR due to various reasons. To better understand this variation, the present study investigated preoperative information provision to patients and personal opinions of surgical oncologists and plastic surgeons towards potential contra-indications for IBR. METHODS: An online survey (35 questions) was developed including questions on respondent demographics, information provision to the patient about IBR and potential contra-indications by IBR technique. RESULTS: One-hundred-eighty-nine physicians participated: 118 surgical oncologists and 71 plastic surgeons. All clinicians discussed the possibility of IBR with their patients. Complications (79% versus 100%, P < 0.001) and aesthetic outcomes (83% versus 99%, P = 0.001) were discussed less frequently by surgical oncologists than by plastic surgeons.Patient age >75 years, breast size >D-cup, BMI >40 kg/m, smoking (for implant reconstruction), pulmonary/cardiac comorbidities (for autologous reconstruction) and radiotherapy were considered a contra-indication more frequently by plastic surgeons. In contrast, surgical oncologists reported tumor stage (≥cT3), nodal stage (≥cN2) and chemotherapy more frequently to be a contra-indication for IBR. CONCLUSION: We observed that all respondents discussed the possibility of IBR with their patients, whereas patient-tailored information was given more frequently by plastic surgeons. Physicians differed in their opinions towards contra-indications for IBR, with plastic surgeons reporting patient-related risk factors for wound healing problems and surgical oncologists reporting oncological contra-indications more frequently. Consensus between physicians regarding contra-indications for IBR may optimize patient counseling and shared decision-making.
引用
- van Bommel ACM, Schreuder K, Veenstra RK, et al. Discrepancies Between Surgical Oncologists and Plastic Surgeons in Patient Information Provision and Personal Opinions Towards Immediate Breast Reconstruction. Ann Plast Surg. 2018. PMID: 30067531. doi:10.1097/SAP.0000000000001572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。